Alimera Sciences to Report First Quarter 2022 Financial Results on Monday, May 9, 2022, and Provide Corporate Update
Alimera Sciences (Nasdaq: ALIM) will report its first quarter financial results on May 9, 2022, before the market opens. A conference call is scheduled for 9:00 AM ET the same day to discuss these results and provide updates on corporate developments. Registered participants will receive a dial-in number, and the call will be accessible via a live webcast. A replay will be available for a limited time after the call. Alimera focuses on retinal health and improving vision for patients.
- None.
- None.
Conference Call to be held the same day at 9:00am Eastern Time
ATLANTA, May 06, 2022 (GLOBE NEWSWIRE) -- Alimera Sciences, Inc. (Nasdaq: ALIM) (Alimera), a global pharmaceutical company whose mission is to be invaluable to patients, physicians and partners concerned with retinal health and maintaining better vision longer, announces today that it will report first quarter financial results on Monday, May 9, 2022, prior to the market open.
Management will host a conference call at 9:00 AM ET on the same day, to review financial results and provide an update on corporate developments. Following management’s formal remarks, there will be a question-and-answer session.
Participants are asked to pre-register for the call.
Please note that registered participants will receive their dial-in number upon registration and will dial directly into the call without delay. Those without Internet access or who are unable to pre-register may dial in by calling 1-844-839-2190 (domestic) or 1-412-717-9583 (international). All callers should dial in approximately 10 minutes prior to the scheduled start time and ask to be joined into the Alimera Sciences call.
The conference call will also be available through a live webcast, which is also available through the company’s website.
A webcast replay of the call will be available approximately one hour after the end of the call through August 9, 2022. The webcast replay can be accessed through the above links or by calling 1-877-344-7529 (domestic) or 1-412-317-0088 (international) and using access code 9842780. The telephonic replay will be available until May 23, 2022.
About Alimera Sciences, Inc.
Alimera Sciences a global pharmaceutical company whose mission is to be invaluable to patients, physicians and partners concerned with retinal health and maintaining better vision longer. For more information, please visit www.alimerasciences.com.
For press inquiries: | For investor inquiries: |
Jules Abraham | Scott Gordon |
for Alimera Sciences | for Alimera Sciences |
917-885-7378 | scottg@coreir.com |
julesa@coreir.com |
FAQ
When will Alimera Sciences report Q1 financial results?
What time is the Alimera Sciences conference call?
How can I access the Alimera Sciences conference call?